trial · primary record
Mitapivat Matched Placebo
Sickle Cell Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 159 |
| Primary completion | 2030-08 |
| Primary endpoint | Percentage of Subjects who are Transfusion Free From Week 4 Through Week 52 |
| Registry ID | NCT07656415 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:04.978Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07656415
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.